Metaplastic Carcinoma of the Breast: p53 Analysis Identified the Same Point Mutation in the Three Histologic Components
- 1 November 2001
- journal article
- case report
- Published by Elsevier BV in Laboratory Investigation
- Vol. 14 (11), 1183-1186
- https://doi.org/10.1038/modpathol.3880456
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- p63 Is a Prostate Basal Cell Marker and Is Required for Prostate DevelopmentThe American Journal of Pathology, 2000
- Detection of Gene Amplification in Archival Breast Cancer Specimens by Laser-Assisted Microdissection and Quantitative Real-Time Polymerase Chain ReactionThe American Journal of Pathology, 2000
- Association of p63 with Proliferative Potential in Normal and Neoplastic Human KeratinocytesJournal of Investigative Dermatology, 1999
- Overexpression and genetic abnormality of p53 in parathyroid adenomas.Pathology International, 1999
- p63, a p53 Homolog at 3q27–29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative ActivitiesMolecular Cell, 1998
- Carcinomas with Metaplasia and Sarcomas of the BreastAmerican Journal of Clinical Pathology, 1991
- Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal originCancer, 1990
- Metaplastic carcinomas of the breast. III. CarcinosarcomaCancer, 1989
- Carcinoma of the breast with pseudosarcomatous metaplasiaCancer, 1984
- Mucoepidermoid and squamous cell carcinomas of breast with reference to squamous metaplasia and giant cell tumorsThe American Journal of Surgical Pathology, 1983